Xzōm is building a point-of-care capable, exosome-based liquid biopsy foundational technology that delivers clinically actionable results in ~30 minutes. Xeed™, our first-in-class on-chip exosome isolation and analysis technology, integrates a device and consumable cartridge with AI-driven analysis to isolate exosomes and extract rich biomarker information quickly and seamlessly, without the need for complex manual workflows or centralized laboratory instruments – all while using minimal sample volume.

Designed as a disease-agnostic and modular platform, Xeed supports a broad continuum of applications for partners across biopharma, diagnostics, and life science research—from early detection and recurrence monitoring to rapid pathogen surveillance, companion diagnostics, risk stratification, treatment response monitoring, and more.  

Our mission is to bring timely, accurate, and affordable insights to everyone, everywhere.